Boldenone Undecylenate by Hilma Biocare

Trade Names: Equi, Equiplex, Equipoise

Chemical Names: Boldenone Undecylenate

Routes: Intramuscular Injection

Half-life: 14 days

Boldenone Undecylenate (Hilma Biocare)

Hilma Biocare produces Boldenone Undecylenate as an injectable anabolic-androgenic steroid (AAS) intended for intramuscular use. It is widely recognized in bodybuilding and performance-enhancement circles for its ability to promote steady gains in lean muscle mass and improve nitrogen retention.

Product Specifications

• Manufacturer: Hilma Biocare
• Active Ingredient: Boldenone Undecylenate
• Ester: Undecylenate (provides a long-acting, sustained release profile)
• Form: Injectable solution (oil-based)
• Standard Concentration: Typically supplied in 200 mg/ml or 250 mg/ml vials (varies by regional packaging)

Pharmacodynamics

The Boldenone molecule is chemically a derivative of testosterone, modified with a double bond at the C1C1​ and C2C2​ positions. This modification significantly reduces the rate at which the hormone converts to estrogen via the aromatase enzyme, compared to testosterone.

• Mechanism of Action: The undecylenate ester causes the hormone to be released slowly from the depot site. This results in a gradual rise in serum concentration, allowing for less frequent injection schedules compared to short-ester steroids.
• Anabolic/Androgenic Ratio: While often marketed as having a balanced ratio, the compound provides strong anabolic effects with comparatively lower androgenic side effects than many other synthetic derivatives.
  
  

Clinical Considerations for Hilma Biocare Products

• Sterility and Quality: Hilma Biocare products are manufactured in pharmaceutical-grade facilities. As with any injectable, maintaining strict aseptic technique during administration is critical to avoid injection-site infections or abscesses.
• Dose-Response: The therapeutic effects—including muscle protein synthesis and increased red blood cell production—are highly dose-dependent. Typical usage protocols in non-medical settings often involve weekly dosages to maintain stable blood plasma levels, despite the long half-life of the ester.
• Side Effect Profile:
• Hematological: Boldenone is known for significantly increasing red blood cell counts, which may elevate hematocrit levels and increase blood viscosity; monitoring blood pressure and cardiovascular markers is recommended.
• Aromatization: Although mild, conversion to estradiol still occurs. Users prone to estrogenic side effects may still require ancillary medications (e.g., SERMs or AI) depending on individual sensitivity and total weekly dosage.